Table 3. Treatment of hyperuricemia.
| BMI <25 kg/m2 (n=1296) | BMI ≥25 kg/m2 (n=3382) | P-value | |
|---|---|---|---|
| Use of allopirunol, n | 379(29.2) | 2031(60.1) | <0.05 |
| Use of febuxostat, n | 82(6.3) | 189(5.6) | >0.05 |
| Use of benzbromarone, n | 367(28.3) | 228(6.7) | <0.05 |
| Use of combination urate-lowering therapies, n | 35(2.7) | 577(17.1) | <0.05 |
| Lifestyle intervention only, n | 433(33.4) | 357(10.6) | <0.05 |